These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36789402)

  • 21. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM
    Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined serum carcinoembryonic antigen and cytokeratin 19 fragment levels provide a sensitive biomarker for lymph node metastasis in extramammary Paget's disease.
    Kato H; Nakamura M; Watanabe S; Oda T; Morita A
    J Dermatol; 2020 Jul; 47(7):763-769. PubMed ID: 32415799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer.
    Bi H; Yin L; Fang W; Song S; Wu S; Shen J
    Lab Med; 2023 Jul; 54(4):372-379. PubMed ID: 36282321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers.
    Falzarano R; Viggiani V; Michienzi S; Longo F; Tudini S; Frati L; Anastasi E
    Tumour Biol; 2013 Oct; 34(5):3093-100. PubMed ID: 23775009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors.
    Chen F; Shen J; Wang J; Cai P; Huang Y
    Cancer Manag Res; 2018; 10():1313-1318. PubMed ID: 29861641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer.
    Stokkel LE; van Rossum HH; van de Kamp MW; Boellaard TN; Bekers EM; Kok NFM; van Rhijn BWG; Mertens LS
    Urol Oncol; 2023 Jul; 41(7):326.e17-326.e24. PubMed ID: 36813613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C.
    Assmar M; Yeganeh S; Mansourghanaei F; Amirmozafari N
    Iran J Public Health; 2016 Dec; 45(12):1645-1651. PubMed ID: 28053931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sources of variation and establishment of Russian reference intervals for major hormones and tumor markers.
    Ruzhanskaya A; Ichihara K; Evgina S; Skibo I; Vybornova N; Vasiliev A; Agarkova G; Emanuel V
    PLoS One; 2021; 16(1):e0234284. PubMed ID: 33411740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt?
    Tuzun Y; Celik Y; Bayan K; Yilmaz S; Dursun M; Canoruc F
    J Int Med Res; 2009; 37(1):79-86. PubMed ID: 19215676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?
    Szekanecz E; Sándor Z; Antal-Szalmás P; Soós L; Lakos G; Besenyei T; Szentpétery A; Simkovics E; Szántó J; Kiss E; Koch AE; Szekanecz Z
    Ann N Y Acad Sci; 2007 Jun; 1108():359-71. PubMed ID: 17893999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reference Intervals of Alpha-Fetoprotein and Carcinoembryonic Antigen in the Apparently Healthy Population.
    Zhang GM; Guo XX; Ma XB; Zhang GM
    Med Sci Monit; 2016 Dec; 22():4875-4880. PubMed ID: 27941709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-analytical stability of the CEA, CYFRA 21.1, NSE, CA125 and HE4 tumor markers.
    Canki E; Schuurbiers MM; Linders TC; Korse CM; van den Heuvel MM; van Herwaarden AE; van Rossum HH
    Tumour Biol; 2024; 46(s1):S15-S25. PubMed ID: 37302060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
    Zhu FL; Ling AS; Wei Q; Ma J; Lu G
    Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-Sectional Study to Establish the Utility of Serum Tumor Markers in the Diagnosis of Lung Cancer.
    Mehta A; Parkash A; Bhatia M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2569-2576. PubMed ID: 34452572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.
    Chen ZQ; Huang LS; Zhu B
    Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The determination of medical reference values for tumor markers in cerebrospinal fluid].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Cao XT
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):355-6. PubMed ID: 19563718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.